Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets (Unaudited)

v3.21.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 421,398 $ 272,092
Short-term Deposits 109,000 27,000
Accounts receivable, net of allowance for credit losses of $0.9 million as of March 31, 2021 and December 31, 2020 102,780 106,068
Inventories 124,199 131,672
Prepaid expenses 10,345 6,717
Other current assets 16,745 16,943
Total current assets 784,467 560,492
Non-current assets    
Property, plant and equipment, net 199,382 201,232
Goodwill 38,074 35,694
Other intangible assets, net 131,619 131,569
Operating lease right-of-use assets 19,089 21,298
Other non-current assets 43,299 39,717
Total non-current assets 431,463 429,510
Total assets 1,215,930 990,002
Current liabilities    
Accounts payable 28,062 16,987
Accrued expenses and other current liabilities 29,283 31,061
Accrued compensation and related benefits 30,937 25,659
Deferred revenues - short term 49,413 49,165
Operating lease liabilities - short term 8,941 9,282
Total current liabilities 146,636 132,154
Non-current liabilities    
Deferred revenues - long term 14,074 14,227
Operating lease liabilities - long term 10,501 12,567
Contingent consideration 40,234 37,400
Other non-current liabilities 32,470 34,059
Total non-current liabilities 97,279 98,253
Total liabilities 243,915 230,407
Contingencies (see note 12)
Redeemable non-controlling interests 227 227
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousand shares; 65,218 thousand shares and 56,617 thousand shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 181 155
Additional paid-in capital 2,984,048 2,753,955
Accumulated other comprehensive loss (7,634) (8,846)
Accumulated deficit (2,004,807) (1,985,896)
Total equity 971,788 759,368
Total liabilities and equity $ 1,215,930 $ 990,002